HCG Collective Intelligence is the industry-leading, thought leadership program powered by the global expertise of the Healthcare Consultancy Group (HCG). It provides leading medical communications professionals across pharma and biotech with transformational examples of future thinking, innovation and communication excellence.
Powered by the expertise of our 1,000+ staff members across our 7 distinct agencies, our research, thought development and innovation for the sector is driven by HCG FUTURUM – our global future-focused think-tank initiative, and our array of expert task forces spanning key areas including Health Disparities & Inequities, Artificial Intelligence, Metaverse, Omnichannel, Genetic Medicine and Generational Engagement.
HCG’s agencies are united in a common vision: to accelerate product understanding and acceptance, bringing clients’ medicines closer to the patients who need them.
Medical communications is transforming in its science and data, audience, technology and channels of HCP communications and the role of medical affairs. This paper, in collaboration with Reuters with expert insight from medcomms leaders, explores this transformation and how pharma companies are seeking to seize this opportunity in practice and deliver on the new mission expected of them.
Through a future-focused think-tank and interviews with medical communications specialists from pharma, see how HCG identified 4 key shifts impacting medical communications and how the investment in each will be critical to ensure we are meeting the needs of health care providers.
Addressing health disparities and inequities can still appear an uphill task. At Healthcare Consultancy Group we have put forward a framework for our teams to leverage with their clients to help develop and disseminate content using the language of and from the perspective of the patient.
How can medical communications play a role in making healthcare more equitable? Read on to learn more about our approach to operationalizing awareness of health disparities and inequities in our business practices and to developing content accordingly.
In partnership with Reuters, join experts from AstraZeneca, Johnson & Johnson, and Pfizer for a panel discussion hosted by HCG as they address how to elevate the conversation around health disparities and inequities in medical communications to ensure health outcomes are improved across all underserved patient populations.
In this webinar, experts from HCG’s Health Disparities & Inequities Task Force address how the medical communications industry can ensure that materials actively communicate and educate HCPs on this topic. They will uncover a framework that can leveraged for every client, therapeutic area, or product, to move the needle towards a more equitable distribution of information and access.
Generative AI is going to transform the way HCPs and patients seek information.
AI technologies have the capacity to revolutionize the practice of medicine – if HCPs can learn to trust them first. Our experts will discuss the current challenges faced with AI and some steps we can take to educate HCPs and move them along the AI adoption spectrum from skepticism to acceptance to advocacy.
AI has become a ubiquitous buzzword in many industries, but how can medical affairs effectively integrate this growing technology to improve efficiency and provide value in medical education today? As healthcare professionals (HCPs) continue to face a stream of new information, and pharmaceutical, biotech, and medical device companies continue to vie for their attention, leveraging AI capabilities poses a very real solution across the industry.
AI technologies have the capacity to revolutionize the practice of medicine – if HCPs can learn to trust them first. Our experts will discuss the current challenges faced with AI and some steps we can take to educate HCPs and move them along the AI adoption spectrum from skepticism to acceptance to advocacy.
Systematic literature review is one of the more time-and resource-consuming undertakings in pharma. In this article, our experts explain how new developments in artificial intelligence and machine learning are making this process substantially more efficient and the new possibilities it opens for the pharma industry.
In this webinar in partnership with Reuters, experts from HCG, OHG, GSK, Novartis, and Pfizer discuss how to leverage data and insights, use new technologies, and create engaging content to deliver personalized medical education to HCPs.
In this webinar, experts from HCG and OHG explore how to leverage data and create engaging content through new technologies to deliver personalized medical education to our HCPs.
Gather insights from our experts here at HCG on delivering personalized and actionable content to an HCP at every point in their journey. Additionally, read on to understand how to measure and analyze the success of each engagement in order to adapt the content, channels, and timing to improve effectiveness and fulfil HCPs’ unmet needs.
The total amount of data that an HCP needs to consume has significantly increased since the dawn of the smartphone era. On average, the data consumed were 2 zettabytes in 2010, and in 2025, the projected consumption of data will be 181 zettabytes.
Read on to learn about our approach to tackling this using omnichannel.
Join an HCG cross-functional panel as they discuss the Precision Medical Education journey and how it will lead to personalized, actionable content, and when and where it will have the greatest impact. The panel will also discuss how to measure and analyze successes through an engagement and how to adapt the content, channels, and timing to improve effectiveness over time.
Brought to you by HCG’s Publication Center of Excellence, this webinar brings together industry speakers from AstraZeneca, Bayer, and ISMPP to share insights on the latest trends that are transforming the publications’ landscape.
In this webinar, HCG’s publication and medical affairs experts discuss some quick tips that can make an impact on scientific communications plans.
The coronavirus pandemic pushed medical communications into the digital age. In this article our Global Director at HCG, Jeremy Williams, offers insights as to why social media channels are key in engaging healthcare professionals.
COVID-19 significantly changed consumer behaviors and required pharma to rethink how we engage and educate HCPs. Our experts discuss how to prepare for the new future of medical communications, taking learnings from what we've witnessed and experienced over the last several years to propel our engagements forward.
Our experts discuss the need to think personal and snackable when developing content, the evolution to “Content 3.0,” and how to master the new landscape to engage HCPs and key opinion leaders (KOLs) on social media.
Members from the HCG Engagement Group, an industry powerhouse collection of 115+ digital, creative, and innovation experts, discuss a strategy for effective knowledge building among HCP audiences, tactical real-world examples and considerations, and a framework for leveraging data-driven audience segmentation and social network engagement.
The Science Behind Learning: Evidence-Based Principles to Improve HCP Engagement
Medical, scientific, and creative experts translate learning theory research into best practices for improving HCP engagement. An overview of research in learning techniques and methodologies, actionable real-world examples, and a framework for integrating learning principles into future medical communications will be provided.
The influence of the digital opinion leaders continues to grow but identifying the right DOL to partner with can be a challenge. Our experts offer their advice on the art of DOL identification and explain how this process is becoming more scientific.
You’ve heard it, DOLs are the new KOLs—and this model is here to stay. From identifying them through a common passion to building this relationship, we’ve been there, done that, and we’re ready to take you on this journey!
With the rise of online HCP presence, a new breed of KOLs have emerged—DOLs. Our experts will provide their key insights on identification, engagement, and advocacy in this article.
HCG experts provide their perspective on the evolving role of DOLs in medical and marketing communications and share their approaches for identifying, monitoring, and engaging DOLs in a compliant manner, with relevant examples.
It’s never been a matter of where to engage HCPs, but with more spending increased time online and with an increased number using social media for professional services, medical affairs teams need to keep up.
Read on, and we’ll provide real work examples on how to engage HCPs on social media through every step of this new journey.
A cross-functional panel discusses the trends in medical communications toward increased HCP engagement on social media, the need to proactively identify and seize opportunities under this new engagement paradigm, and practical real-world examples to effectively facilitate compliant HCP social media engagement.
Learn strategies on how to engage an HCP audience at virtual congresses—from the virtual booth to relationship building, the increased audience size, to content. Anyone trying to engage HCPs in a virtual environment need to rethink their strategy, and we have a few suggestions on how.
A multidisciplinary expert HCG panel discusses HCP attitudes, opinions, and preferences on the return to live events, as told by HCPs themselves. The panel discusses “what’s next” in HCP engagement and provides insights on integrated multichannel strategies for connecting and communicating with both live and virtual audiences during hybrid programs.
Communication professionals engage a cross-functional panel to discuss challenges, share learnings, and highlight best practices when presenting at a virtual (or hybrid) congress, based on findings from 100 virtual congresses. The panel investigates competitive differentiation and how to maximize audience outreach using real-life examples.
Data-dissemination and digital experts provide perspectives on what congress disruption means for medical communications strategy to equip attendees with practical solutions for data dissemination and HCP engagement.
The most common factors for underperforming drug launches between 2012 and 2017 in the United States were limited market access, inadequate understanding of customer needs and poor product differentiation. Learn from our experts how HE models, and RWE can be used to overcome these challenges.
Our cross-functional panel discusses the US landscape in rare disease and the challenges for health care access, creating value propositions and solutions, and the role of innovative real-world data strategies and communication channels for optimal engagement of all stakeholders.
HCG hosts a panel of industry experts to discuss how to interpret data from clinical trials disrupted by the COVID-19 pandemic and how to best communicate these data with regulators.
An HCG and industry expert panel discusses how to prepare a high-quality product concept document and develop specifications around the components of the product. They also consider how to effectively use these utility documents to guide regulatory, business development, scientific, and market-entry strategy and development.
Healthcare Consultancy Group (HCG) is a global leader in medical communications – 7 agencies united in a common vision: to accelerate product understanding and acceptance, bringing clients’ medicines closer to the patients who need them. With global offices of around 1000+ staff spanning North America, Europe and Asia, HCG is an incubator for the relentlessly curious. Our appetite for creating strategies that lead to better patient outcomes is never satisfied.
